Skip to main content
. Author manuscript; available in PMC: 2013 Nov 5.
Published in final edited form as: Mol Pharm. 2012 Oct 16;9(11):3218–3227. doi: 10.1021/mp300303k

Figure 7.

Figure 7

After treatment of HPB-MLT cells with bisMTX-FITC containing CSANs, incubation with trimethoprim causes a rapid decrease in fluorescence, as compared to a slow decrease for untreated cells or cells treated with FITC labeled UCHT-1 as observed by flow cytometry.